Search

Your search keyword '"Fetsch, Patricia"' showing total 287 results
Start Over Author "Fetsch, Patricia"
287 results on '"Fetsch, Patricia"'

1. Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors

Author

Cole, Christopher B., Morelli, Maria Pia, Fantini, Massimo, Miettinen, Markku, Fetsch, Patricia, Peer, Cody, Figg, William D., Yin, Tyler, Houston, Nicole, McCoy, Ann, Lipkowitz, Stanley, Zimmer, Alexandra, Lee, Jung-min, Pavelova, Miroslava, Villanueva, Erin N., Trewhitt, Kathryn, Solarz, B. Brooke, Fergusson, Maria, Mavroukakis, Sharon A., Zaki, Anjum, Tsang, Kwong Y., Arlen, Philip M., and Annunziata, Christina M.

Published
2023
Full Text
View/download PDF

2. First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors

Author

Cole, Christopher B., Morelli, Maria Pia, Fantini, Massimo, Miettinen, Markku, Fetsch, Patricia, Peer, Cody, Figg, William D., Yin, Tyler, Houston, Nicole, McCoy, Ann, Lipkowitz, Stanley, Zimmer, Alexandra, Lee, Jung-min, Pavelova, Miroslava, Villanueva, Erin N., Trewhitt, Kathryn, Solarz, B. Brooke, Fergusson, Maria, Mavroukakis, Sharon A., Zaki, Anjum, Tsang, Kwong Y., Arlen, Philip M., and Annunziata, Christina M.

Published
2023
Full Text
View/download PDF

3. Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define pre-malignant neurofibromatosis type 1-associated atypical neurofibromas

Author

Pemov, Alexander, Hansen, Nancy F, Sindiri, Sivasish, Patidar, Rajesh, Higham, Christine S, Dombi, Eva, Miettinen, Markku M, Fetsch, Patricia, Brems, Hilde, Chandrasekharappa, Settara, Jones, Kristine, Zhu, Bin, Wei, Jun S, Mullikin, James C, Wallace, Margaret R, Khan, Javed, Legius, Eric, Widemann, Brigitte C, and Stewart, Douglas R

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Human Genome, Neurofibromatosis, Rare Diseases, Neurosciences, Genetics, Pediatric, Cancer, Cyclin-Dependent Kinase Inhibitor p15, Cyclin-Dependent Kinase Inhibitor p16, Humans, Mutation, Nerve Sheath Neoplasms, Neurofibroma, Neurofibroma, Plexiform, Neurofibromatosis 1, Neurofibrosarcoma, Transcription Factors, atypical neurofibromas, benign-to-malignant transformation, malignant peripheral nerve sheath tumor, neurofibromatosis type 1, plexiform neurofibromas, National Intramural Sequencing Center (NISC) Comparative Sequencing Program, National Cancer Institute (NCI) Division of Cancer Epidemiology and Genetics (DCEG) Cancer Genomics Research Laboratory, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

BackgroundNeurofibromatosis type 1 (NF1) is a tumor-predisposition disorder caused by germline mutations in NF1. NF1 patients have an 8-16% lifetime risk of developing a malignant peripheral nerve sheath tumor (MPNST), a highly aggressive soft-tissue sarcoma, often arising from preexisting benign plexiform neurofibromas (PNs) and atypical neurofibromas (ANFs). ANFs are distinct from both PN and MPNST, representing an intermediate step in malignant transformation.MethodsIn the first comprehensive genomic analysis of ANF originating from multiple patients, we performed tumor/normal whole-exome sequencing (WES) of 16 ANFs. In addition, we conducted WES of 3 MPNSTs, copy-number meta-analysis of 26 ANFs and 28 MPNSTs, and whole transcriptome sequencing analysis of 5 ANFs and 5 MPNSTs.ResultsWe identified a low number of mutations (median 1, range 0-5) in the exomes of ANFs (only NF1 somatic mutations were recurrent), and frequent deletions of CDKN2A/B (69%) and SMARCA2 (42%). We determined that polycomb repressor complex 2 (PRC2) genes EED and SUZ12 were frequently mutated, deleted, or downregulated in MPNSTs but not in ANFs. Our pilot gene expression study revealed upregulated NRAS, MDM2, CCND1/2/3, and CDK4/6 in ANFs and MPNSTs, and overexpression of EZH2 in MPNSTs only.ConclusionsThe PN-ANF transition is primarily driven by the deletion of CDKN2A/B. Further progression from ANF to MPNST likely involves broad chromosomal rearrangements and frequent inactivation of the PRC2 genes, loss of the DNA repair genes, and copy-number increase of signal transduction and cell-cycle and pluripotency self-renewal genes.

Published
2019

5. Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression

Author

Rathkey, Daniel, Khanal, Manakamana, Murai, Junko, Zhang, Jingli, Sengupta, Manjistha, Jiang, Qun, Morrow, Betsy, Evans, Christine N., Chari, Raj, Fetsch, Patricia, Chung, Hye-Jung, Xi, Liqiang, Roth, Mark, Filie, Armando, Raffeld, Mark, Thomas, Anish, Pommier, Yves, and Hassan, Raffit

Published
2020
Full Text
View/download PDF

6. Supplementary Table 3 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Author

Bartlett, Edmund K., primary, Fetsch, Patricia A., primary, Filie, Armando C., primary, Abati, Andrea, primary, Steinberg, Seth M., primary, Wunderlich, John R., primary, White, Donald E., primary, Stephens, Daniel J., primary, Marincola, Francesco M., primary, Rosenberg, Steven A., primary, and Kammula, Udai S., primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure 2 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table 6 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure S5 from Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells

Author

Rao, Mahadev, primary, Atay, Scott M., primary, Shukla, Vivek, primary, Hong, Young, primary, Upham, Trevor, primary, Ripley, R. Taylor, primary, Hong, Julie A., primary, Zhang, Mary, primary, Reardon, Emily, primary, Fetsch, Patricia, primary, Miettinen, Markku, primary, Li, Xinmin, primary, Peer, Cody J., primary, Sissung, Tristan, primary, Figg, William D., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figure 2 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Author

Bartlett, Edmund K., primary, Fetsch, Patricia A., primary, Filie, Armando C., primary, Abati, Andrea, primary, Steinberg, Seth M., primary, Wunderlich, John R., primary, White, Donald E., primary, Stephens, Daniel J., primary, Marincola, Francesco M., primary, Rosenberg, Steven A., primary, and Kammula, Udai S., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table S1 from Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells

Author

Rao, Mahadev, primary, Atay, Scott M., primary, Shukla, Vivek, primary, Hong, Young, primary, Upham, Trevor, primary, Ripley, R. Taylor, primary, Hong, Julie A., primary, Zhang, Mary, primary, Reardon, Emily, primary, Fetsch, Patricia, primary, Miettinen, Markku, primary, Li, Xinmin, primary, Peer, Cody J., primary, Sissung, Tristan, primary, Figg, William D., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table 1 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Author

Bartlett, Edmund K., primary, Fetsch, Patricia A., primary, Filie, Armando C., primary, Abati, Andrea, primary, Steinberg, Seth M., primary, Wunderlich, John R., primary, White, Donald E., primary, Stephens, Daniel J., primary, Marincola, Francesco M., primary, Rosenberg, Steven A., primary, and Kammula, Udai S., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 2 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Author

Bartlett, Edmund K., primary, Fetsch, Patricia A., primary, Filie, Armando C., primary, Abati, Andrea, primary, Steinberg, Seth M., primary, Wunderlich, John R., primary, White, Donald E., primary, Stephens, Daniel J., primary, Marincola, Francesco M., primary, Rosenberg, Steven A., primary, and Kammula, Udai S., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table 1 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure 4 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 1 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Author

Bartlett, Edmund K., primary, Fetsch, Patricia A., primary, Filie, Armando C., primary, Abati, Andrea, primary, Steinberg, Seth M., primary, Wunderlich, John R., primary, White, Donald E., primary, Stephens, Daniel J., primary, Marincola, Francesco M., primary, Rosenberg, Steven A., primary, and Kammula, Udai S., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Materials and Methods from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 6 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure 3 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Table 5 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 1 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table 4 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Author

Bartlett, Edmund K., primary, Fetsch, Patricia A., primary, Filie, Armando C., primary, Abati, Andrea, primary, Steinberg, Seth M., primary, Wunderlich, John R., primary, White, Donald E., primary, Stephens, Daniel J., primary, Marincola, Francesco M., primary, Rosenberg, Steven A., primary, and Kammula, Udai S., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table 2 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table 3 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 5 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Table 4 from Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Author

Kemp, Clinton D., primary, Rao, Mahadev, primary, Xi, Sichuan, primary, Inchauste, Suzanne, primary, Mani, Haresh, primary, Fetsch, Patricia, primary, Filie, Armando, primary, Zhang, Mary, primary, Hong, Julie A., primary, Walker, Robert L., primary, Zhu, Yuelin J., primary, Ripley, R. Taylor, primary, Mathur, Aarti, primary, Liu, Fang, primary, Yang, Maocheng, primary, Meltzer, Paul A., primary, Marquez, Victor E., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Methods from Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells

Author

Rao, Mahadev, primary, Atay, Scott M., primary, Shukla, Vivek, primary, Hong, Young, primary, Upham, Trevor, primary, Ripley, R. Taylor, primary, Hong, Julie A., primary, Zhang, Mary, primary, Reardon, Emily, primary, Fetsch, Patricia, primary, Miettinen, Markku, primary, Li, Xinmin, primary, Peer, Cody J., primary, Sissung, Tristan, primary, Figg, William D., primary, De Rienzo, Assunta, primary, Bueno, Raphael, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table 2 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells

Author

Zhang, Mary, primary, Mathur, Aarti, primary, Zhang, Yuwei, primary, Xi, Sichuan, primary, Atay, Scott, primary, Hong, Julie A., primary, Datrice, Nicole, primary, Upham, Trevor, primary, Kemp, Clinton D., primary, Ripley, R. Taylor, primary, Wiegand, Gordon, primary, Avital, Itzak, primary, Fetsch, Patricia, primary, Mani, Haresh, primary, Zlott, Daniel, primary, Robey, Robert, primary, Bates, Susan E., primary, Li, Xinmin, primary, Rao, Mahadev, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Table 3 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells

Author

Zhang, Mary, primary, Mathur, Aarti, primary, Zhang, Yuwei, primary, Xi, Sichuan, primary, Atay, Scott, primary, Hong, Julie A., primary, Datrice, Nicole, primary, Upham, Trevor, primary, Kemp, Clinton D., primary, Ripley, R. Taylor, primary, Wiegand, Gordon, primary, Avital, Itzak, primary, Fetsch, Patricia, primary, Mani, Haresh, primary, Zlott, Daniel, primary, Robey, Robert, primary, Bates, Susan E., primary, Li, Xinmin, primary, Rao, Mahadev, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure 4 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells

Author

Zhang, Mary, primary, Mathur, Aarti, primary, Zhang, Yuwei, primary, Xi, Sichuan, primary, Atay, Scott, primary, Hong, Julie A., primary, Datrice, Nicole, primary, Upham, Trevor, primary, Kemp, Clinton D., primary, Ripley, R. Taylor, primary, Wiegand, Gordon, primary, Avital, Itzak, primary, Fetsch, Patricia, primary, Mani, Haresh, primary, Zlott, Daniel, primary, Robey, Robert, primary, Bates, Susan E., primary, Li, Xinmin, primary, Rao, Mahadev, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

31. Data from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells

Author

Zhang, Mary, primary, Mathur, Aarti, primary, Zhang, Yuwei, primary, Xi, Sichuan, primary, Atay, Scott, primary, Hong, Julie A., primary, Datrice, Nicole, primary, Upham, Trevor, primary, Kemp, Clinton D., primary, Ripley, R. Taylor, primary, Wiegand, Gordon, primary, Avital, Itzak, primary, Fetsch, Patricia, primary, Mani, Haresh, primary, Zlott, Daniel, primary, Robey, Robert, primary, Bates, Susan E., primary, Li, Xinmin, primary, Rao, Mahadev, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 3 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells

Author

Zhang, Mary, primary, Mathur, Aarti, primary, Zhang, Yuwei, primary, Xi, Sichuan, primary, Atay, Scott, primary, Hong, Julie A., primary, Datrice, Nicole, primary, Upham, Trevor, primary, Kemp, Clinton D., primary, Ripley, R. Taylor, primary, Wiegand, Gordon, primary, Avital, Itzak, primary, Fetsch, Patricia, primary, Mani, Haresh, primary, Zlott, Daniel, primary, Robey, Robert, primary, Bates, Susan E., primary, Li, Xinmin, primary, Rao, Mahadev, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Table 1 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells

Author

Zhang, Mary, primary, Mathur, Aarti, primary, Zhang, Yuwei, primary, Xi, Sichuan, primary, Atay, Scott, primary, Hong, Julie A., primary, Datrice, Nicole, primary, Upham, Trevor, primary, Kemp, Clinton D., primary, Ripley, R. Taylor, primary, Wiegand, Gordon, primary, Avital, Itzak, primary, Fetsch, Patricia, primary, Mani, Haresh, primary, Zlott, Daniel, primary, Robey, Robert, primary, Bates, Susan E., primary, Li, Xinmin, primary, Rao, Mahadev, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure 2 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells

Author

Zhang, Mary, primary, Mathur, Aarti, primary, Zhang, Yuwei, primary, Xi, Sichuan, primary, Atay, Scott, primary, Hong, Julie A., primary, Datrice, Nicole, primary, Upham, Trevor, primary, Kemp, Clinton D., primary, Ripley, R. Taylor, primary, Wiegand, Gordon, primary, Avital, Itzak, primary, Fetsch, Patricia, primary, Mani, Haresh, primary, Zlott, Daniel, primary, Robey, Robert, primary, Bates, Susan E., primary, Li, Xinmin, primary, Rao, Mahadev, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Methods from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells

Author

Zhang, Mary, primary, Mathur, Aarti, primary, Zhang, Yuwei, primary, Xi, Sichuan, primary, Atay, Scott, primary, Hong, Julie A., primary, Datrice, Nicole, primary, Upham, Trevor, primary, Kemp, Clinton D., primary, Ripley, R. Taylor, primary, Wiegand, Gordon, primary, Avital, Itzak, primary, Fetsch, Patricia, primary, Mani, Haresh, primary, Zlott, Daniel, primary, Robey, Robert, primary, Bates, Susan E., primary, Li, Xinmin, primary, Rao, Mahadev, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 1 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells

Author

Zhang, Mary, primary, Mathur, Aarti, primary, Zhang, Yuwei, primary, Xi, Sichuan, primary, Atay, Scott, primary, Hong, Julie A., primary, Datrice, Nicole, primary, Upham, Trevor, primary, Kemp, Clinton D., primary, Ripley, R. Taylor, primary, Wiegand, Gordon, primary, Avital, Itzak, primary, Fetsch, Patricia, primary, Mani, Haresh, primary, Zlott, Daniel, primary, Robey, Robert, primary, Bates, Susan E., primary, Li, Xinmin, primary, Rao, Mahadev, primary, and Schrump, David S., primary

Published
2023
Full Text
View/download PDF

37. Additional file 2 of First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors

Author

Cole, Christopher B., Morelli, Maria Pia, Fantini, Massimo, Miettinen, Markku, Fetsch, Patricia, Peer, Cody, Figg, William D., Yin, Tyler, Houston, Nicole, McCoy, Ann, Lipkowitz, Stanley, Zimmer, Alexandra, Lee, Jung-min, Pavelova, Miroslava, Villanueva, Erin N., Trewhitt, Kathryn, Solarz, B. Brooke, Fergusson, Maria, Mavroukakis, Sharon A., Zaki, Anjum, Tsang, Kwong Y., Arlen, Philip M., and Annunziata, Christina M.

Abstract

Additional file 2: Supplementary Table 2. Report of all adverse events (grade 1-4) in all patients.

Published
2023
Full Text
View/download PDF

38. Additional file 1 of First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors

Author

Cole, Christopher B., Morelli, Maria Pia, Fantini, Massimo, Miettinen, Markku, Fetsch, Patricia, Peer, Cody, Figg, William D., Yin, Tyler, Houston, Nicole, McCoy, Ann, Lipkowitz, Stanley, Zimmer, Alexandra, Lee, Jung-min, Pavelova, Miroslava, Villanueva, Erin N., Trewhitt, Kathryn, Solarz, B. Brooke, Fergusson, Maria, Mavroukakis, Sharon A., Zaki, Anjum, Tsang, Kwong Y., Arlen, Philip M., and Annunziata, Christina M.

Abstract

Additional file 1: Supplementary Table 1. Genetic alterations of all patients enrolled in the study.

Published
2023
Full Text
View/download PDF

39. Additional file 3 of First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors

Author

Cole, Christopher B., Morelli, Maria Pia, Fantini, Massimo, Miettinen, Markku, Fetsch, Patricia, Peer, Cody, Figg, William D., Yin, Tyler, Houston, Nicole, McCoy, Ann, Lipkowitz, Stanley, Zimmer, Alexandra, Lee, Jung-min, Pavelova, Miroslava, Villanueva, Erin N., Trewhitt, Kathryn, Solarz, B. Brooke, Fergusson, Maria, Mavroukakis, Sharon A., Zaki, Anjum, Tsang, Kwong Y., Arlen, Philip M., and Annunziata, Christina M.

Abstract

Additional file 3: Supplementary Table 3. IHC staining profile of patients enrolled in the study.

Published
2023
Full Text
View/download PDF

44. ABCG2: A perspective

Author

Robey, Robert W., To, Kenneth K.K., Polgar, Orsolya, Dohse, Marius, Fetsch, Patricia, Dean, Michael, and Bates, Susan E.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results